secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0000950170-24-070603
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology shareholders elect all three Class III directors and ratify EY as auditor
--------------------------------------------------------------------------------

- Joshua H. Bilenker, M.D. elected with ~149M votes for, ~16M withheld.
- Richard Mulligan, Ph.D. elected with ~149.6M votes for, ~14.9M withheld.
- Mary Agnes (Maggie) Wilderotter elected with ~144.2M votes for, ~20.3M withheld.
- Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with ~178.5M for, ~65K against.
- Annual meeting held June 6, 2024; all proposals approved as recommended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000095017024070603/0000950170-24-070603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000095017024070603/sana-20240606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-070603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer